Literature DB >> 12359114

Diagnosing asthma in young children.

Jay M Portnoy1, Erika M Jones.   

Abstract

Asthma is a respiratory syndrome that frequently is underdiagnosed, particularly in young children. This primarily results from the lack of clinically useful criteria for making the diagnosis in the absence of objective tests, which are problematic in young children. Because new information suggests that delayed diagnosis may lead to permanently decreased lung function that could be prevented by early treatment, it is important that an accurate diagnosis be made as early as possible. Although simple criteria exist for determining if a patient has asthma, there is a tendency to delay making the diagnosis for a variety of reasons, including the observation that many children who begin wheezing at an early age stop wheezing by the time they are 6 years of age, and concerns over adverse effects from falsely labeling a patient with a potentially stigmatizing condition. Young children who receive an incorrect diagnosis of asthma are at an increased risk of receiving unnecessary medications and may be denied life insurance, health insurance, and admission into the military later in life. On close examination, each of these concerns is unfounded. Early diagnosis of asthma has many potentially positive effects; the negative effects have generally been exaggerated and do not stand up to close scrutiny. Routine use of clinically useful criteria for making the diagnosis, as outlined in this review, may help to simplify the process of making an early diagnosis of asthma.

Entities:  

Mesh:

Year:  2002        PMID: 12359114     DOI: 10.1007/s11882-002-0083-1

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  33 in total

1.  Childhood asthma and lung function in mid-adult life.

Authors:  H Oswald; P D Phelan; A Lanigan; M Hibbert; J B Carlin; G Bowes; A Olinsky
Journal:  Pediatr Pulmonol       Date:  1997-01

Review 2.  Outcome measures in childhood asthma.

Authors:  David P Skoner
Journal:  Pediatrics       Date:  2002-02       Impact factor: 7.124

3.  Response of preschool children with asthma symptoms to fluticasone propionate.

Authors:  R J Roorda; G Mezei; H Bisgaard; C Maden
Journal:  J Allergy Clin Immunol       Date:  2001-10       Impact factor: 10.793

4.  Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project.

Authors:  C P van Schayck; F M van Der Heijden; G van Den Boom; P R Tirimanna; C L van Herwaarden
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

5.  Barriers to asthma care in urban children: parent perspectives.

Authors:  M E Mansour; B P Lanphear; T G DeWitt
Journal:  Pediatrics       Date:  2000-09       Impact factor: 7.124

6.  Once-daily budesonide inhalation suspension in infants and children < 4 and > or = 4 years of age with persistent asthma.

Authors:  M B Scott; M H Ellis; M Cruz-Rivera; S Fitzpatrick; J A Smith
Journal:  Ann Allergy Asthma Immunol       Date:  2001-12       Impact factor: 6.347

7.  Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

Authors:  L Agertoft; S Pedersen
Journal:  Respir Med       Date:  1994-05       Impact factor: 3.415

8.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates.

Authors:  F D Martinez; A L Wright; L M Taussig; C J Holberg; M Halonen; W J Morgan
Journal:  N Engl J Med       Date:  1995-01-19       Impact factor: 91.245

9.  Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice.

Authors:  F P Bryce; R G Neville; I K Crombie; R A Clark; P McKenzie
Journal:  BMJ       Date:  1995-04-01

10.  A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants.

Authors:  J W Baker; M Mellon; J Wald; M Welch; M Cruz-Rivera; K Walton-Bowen
Journal:  Pediatrics       Date:  1999-02       Impact factor: 7.124

View more
  1 in total

Review 1.  Modification of provider behavior to achieve improved asthma outcomes.

Authors:  Erika M Jones; Jay M Portnoy
Journal:  Curr Allergy Asthma Rep       Date:  2003-11       Impact factor: 4.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.